Guocheng Li

584 total citations
20 papers, 482 citations indexed

About

Guocheng Li is a scholar working on Oncology, Molecular Biology and Biomaterials. According to data from OpenAlex, Guocheng Li has authored 20 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Guocheng Li's work include Nanoparticle-Based Drug Delivery (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Guocheng Li is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Guocheng Li collaborates with scholars based in China. Guocheng Li's co-authors include Kaifeng Qiu, Chunxia Liu, Chuxiong Chen, Li Lv, Yonghui Shi, Xiaobin Zheng, Cuiju Wen, Kun-Shui Zhang, Huiqing Chen and Haidi Yang and has published in prestigious journals such as Toxicology and Applied Pharmacology, BioMed Research International and Oncotarget.

In The Last Decade

Guocheng Li

20 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guocheng Li China 10 142 138 97 72 70 20 482
Akhilesh Prajapati India 10 75 0.5× 71 0.5× 84 0.9× 20 0.3× 24 0.3× 19 467
Aparajita Ghosh India 9 160 1.1× 70 0.5× 32 0.3× 15 0.2× 40 0.6× 17 428
Yu-Chun Kuo Taiwan 8 311 2.2× 102 0.7× 68 0.7× 49 0.7× 117 1.7× 9 780
Mostafa Moradi Sarabi Iran 14 261 1.8× 38 0.3× 66 0.7× 28 0.4× 18 0.3× 39 527
Pushkar Singh Rawat India 5 255 1.8× 58 0.4× 154 1.6× 28 0.4× 71 1.0× 8 657
Rupshee Jain India 8 183 1.3× 50 0.4× 60 0.6× 67 0.9× 42 0.6× 17 430
Takayuki Kumano Japan 10 178 1.3× 102 0.7× 69 0.7× 6 0.1× 53 0.8× 16 456
Khalid Zoghebi Saudi Arabia 13 179 1.3× 33 0.2× 39 0.4× 13 0.2× 58 0.8× 40 534
Foram U. Vaidya India 15 223 1.6× 50 0.4× 168 1.7× 8 0.1× 40 0.6× 25 577
Mona A.M. Abo-Zeid Egypt 14 109 0.8× 64 0.5× 25 0.3× 38 0.5× 118 1.7× 32 533

Countries citing papers authored by Guocheng Li

Since Specialization
Citations

This map shows the geographic impact of Guocheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guocheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guocheng Li more than expected).

Fields of papers citing papers by Guocheng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guocheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guocheng Li. The network helps show where Guocheng Li may publish in the future.

Co-authorship network of co-authors of Guocheng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guocheng Li. A scholar is included among the top collaborators of Guocheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guocheng Li. Guocheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Zhicheng, et al.. (2024). Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway. Toxicology and Applied Pharmacology. 494. 117158–117158. 3 indexed citations
2.
Zhang, Guodong, Xiaolan Du, Guocheng Li, et al.. (2023). Transcriptome profile analysis revealed the potential mechanism of LIPUS treatment for Adriamycin-induced chronic kidney disease rat. Heliyon. 9(11). e21531–e21531. 2 indexed citations
3.
Liu, Chang, et al.. (2023). Synthetic Self‐Adjuvanted Lipopeptide Vaccines Conferred Protection against Helicobacter pylori Infection. Advanced Healthcare Materials. 12(23). e2300085–e2300085. 9 indexed citations
4.
Deng, Zhicheng, Yonghui Shi, Ying Lin, et al.. (2022). Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification. Frontiers in Pharmacology. 13. 920514–920514. 38 indexed citations
5.
Shi, Yonghui, et al.. (2021). Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting. International Journal of Nanomedicine. Volume 16. 1487–1508. 17 indexed citations
6.
Liu, Chunxia, Ling Lin, Zhengwei Huang, et al.. (2019). Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol–Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties. AAPS PharmSciTech. 20(2). 85–85. 14 indexed citations
7.
Liu, Chunxia, et al.. (2018). Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study. BioMed Research International. 2018. 1–10. 38 indexed citations
8.
Qiu, Kaifeng, Chunxia Liu, Yonghui Shi, et al.. (2018). An LC-MS/MS Method for Synchronous Determination of Paclitaxel and Curcumin: Development, Validation, and Application to a Pharmacokinetic Study. Current Pharmaceutical Analysis. 15(4). 319–326. 3 indexed citations
9.
Zhu, Jianhong, Wenxia Zhao, Dan Liang, et al.. (2017). Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial. International Journal of Clinical Oncology. 23(2). 389–399. 1 indexed citations
10.
Zhu, Jianhong, Junyan Wu, Guocheng Li, et al.. (2017). Meta-analysis of randomized controlled trials for the incidence and risk of fatal adverse events in cancer patients treated with ipilimumab. Expert Opinion on Drug Safety. 16(4). 423–428. 8 indexed citations
11.
Lv, Li, et al.. (2017). Pharmacokinetics of Quercetin-Loaded Methoxy Poly(ethylene glycol)-b-poly(L-lactic acid) Micelle after Oral Administration in Rats. BioMed Research International. 2017. 1–7. 15 indexed citations
12.
Liu, Chunxia, Chuxiong Chen, Guang‐Hui Chen, et al.. (2016). Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer. Oncotarget. 7(22). 32184–32199. 96 indexed citations
13.
Lv, Li, Kaifeng Qiu, Xiaoxia Yu, et al.. (2016). Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer. Journal of Biomedical Nanotechnology. 12(5). 973–985. 103 indexed citations
14.
15.
Li, Guocheng, et al.. (2015). Ultrasound-Assisted Extraction of Pristimerin from <i>Celastrus orbiculatus</i> Using Response Surface Methodology. Biological and Pharmaceutical Bulletin. 39(1). 97–103. 12 indexed citations
16.
Zhang, Kun-Shui, Huiqing Chen, Kaifeng Qiu, et al.. (2014). Bisphenol A stimulates human lung cancer cell migration via upregulation of matrix metalloproteinases by GPER/EGFR/ERK1/2 signal pathway. Biomedicine & Pharmacotherapy. 68(8). 1037–1043. 112 indexed citations
17.
Li, Guocheng, et al.. (2013). A New Diarylheptanoid from Barks of Mangifera indica. Chinese Herbal Medicines. 5(4). 320–322. 2 indexed citations
18.
Li, Guocheng, et al.. (2010). Determination of Naphazoline Hydrochloride and Chlorphenamine Maleateide in rhinitis nasal drops by HPLC. Guoji yiyao weisheng daobao. 16(2). 192–196. 1 indexed citations
19.
Wu, Junyan, Guocheng Li, & Dingyong Wang. (2007). [Chemical constituents of the non-alkaloid fraction of Uncaria macrophylla].. PubMed. 27(2). 226–7. 3 indexed citations
20.
Li, Guocheng, Junyan Wu, & Rifang Liao. (2003). Determination of zaleplon in blood plasma by RP-HPLC with fluorescence detection. 19(4). 322–324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akhilesh Prajapati Breakdown of academic impact, for papers by Aparajita Ghosh Breakdown of academic impact, for papers by Yu-Chun Kuo Breakdown of academic impact, for papers by Mostafa Moradi Sarabi Breakdown of academic impact, for papers by Pushkar Singh Rawat Breakdown of academic impact, for papers by Rupshee Jain Breakdown of academic impact, for papers by Takayuki Kumano Breakdown of academic impact, for papers by Khalid Zoghebi Breakdown of academic impact, for papers by Foram U. Vaidya Breakdown of academic impact, for papers by Mona A.M. Abo-Zeid
Rankless by CCL
2026